Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02SDX
|
||||
Former ID |
DNC010215
|
||||
Drug Name |
N,N-Dimethyl-3,3-diphenylpropan-1-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530331] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H21N
|
||||
Canonical SMILES |
CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=C2
|
||||
InChI |
1S/C17H21N/c1-18(2)14-13-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3
|
||||
InChIKey |
YHDCGYWZEFIUHE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Inhibitor | [530331] | |
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [530331] | ||
WikiPathways | Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
IL-4 Signaling Pathway | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.